[Management of brain metastases from non-small cell lung carcinoma]

O Bailon; A Kallel; K Chouahnia; S Billot; D Ferrari; A-F Carpentier

doi:10.1016/j.neurol.2011.01.017

[Management of brain metastases from non-small cell lung carcinoma]

Rev Neurol (Paris). 2011 Aug-Sep;167(8-9):579-91. doi: 10.1016/j.neurol.2011.01.017. Epub 2011 May 5.

[Article in French]

Authors

O Bailon¹, A Kallel, K Chouahnia, S Billot, D Ferrari, A-F Carpentier

Affiliation

¹ Service de neurologie, hôpital Avicenne, AP-HP, 125, route de Stalingrad, 93000 Bobigny, France.

PMID: 21546046
DOI: 10.1016/j.neurol.2011.01.017

Abstract

Introduction: In France, approximately 30,000 new patients per year develop brain metastases (BM), most of them resulting from a lung cancer.

State of the art: Surgery and radiosurgery of all the BM must be considered when possible. In other cases, whole brain radiotherapy remains the standard of care.

Perspectives: The role of chemotherapy, poorly investigated so far, should be revisited.

Conclusion: This review focused on BM secondary to a non-small cell lung carcinoma.

Publication types

English Abstract
Review

MeSH terms

Brain Neoplasms / drug therapy*
Brain Neoplasms / radiotherapy
Brain Neoplasms / secondary*
Brain Neoplasms / surgery
Brain Neoplasms / therapy*
Carcinoma, Non-Small-Cell Lung / classification
Carcinoma, Non-Small-Cell Lung / pathology*
Combined Modality Therapy
Humans
Lung Neoplasms / classification
Lung Neoplasms / pathology*
Magnetic Resonance Imaging
Randomized Controlled Trials as Topic